Home > Public Policy : Physician Office Issues
Physician Office Issues
ACCC is committed to ensuring that cancer patients have access to care, including access to the most appropriate cancer therapies. Physicians are able to provide therapies only when they receive adequate reimbursement for the costs of the drug and its administration.
Although Congress intended that the Part B drug changes in the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA) would produce appropriate payment rates for both drugs and drug administration services, ACCC is concerned that our country's oncology infrastructure will be irreparably harmed if CMS does not put patients first when implementing the MMA's reforms.
ACCC continues to monitor, respond, and communicate to our members any changes in Medicare reimbursement to Part B covered drugs and biologicals, drug administration, and coding.
- Highlights of 2009 Physician Fee Schedule (PFS) proposed rule
- Highlights and analysis of 2008 Physician Fee Schedule (PFS) final rule
- Medicare Proposed and Final Physician Rules
- Medicare Proposed and Final ASP Rules
- Medicare Proposed and Final CAP Rules
- Demonstration Projects
Comment Letters:
- ACCC Submits Comments to CMS Regarding 2008 Physician Fee Schedule
- ACCC Comments on the 2007 CMS Proposed Rule Regarding Revisions to Payment Policies Under the Medicare Physician Fee Schedule
- ACCC Comments on Five-Year Review of Work Relative Value Units Under the Physician Fee Schedule and Proposed Changes to the Practice Expense Methodology
- ACCC Comments on Potential Revisions in Practice Expense Methodology for Calendar Year 2007
- ACCC Comments on Physician Fee Schedule 2006
- ACCC Comments on Physician Fee Schedule 2005
- ACCC Comments on CAP Proposed Rule
- ACCC Comments on ASP Final Rule
Press Releases:
Useful Links:
Matt Farber, Manager, Provider Economics & Public Policy,Phone 301.984.9496, ext. 221, Email mfarber@accc-cancer.org
